Susquehanna Portfolio Strategies »

Adaptive Biotechnologies Cor shares owned by Susquehanna Portfolio Strategies

Quarter-by-quarter ownership of Adaptive Biotechnologies Cor (ADPT) shares owned by Susquehanna Portfolio Strategies from 13F filings

Historical chart of Susquehanna Portfolio Strategies investment in Adaptive Biotechnologies Cor

Tip: Access up to 7 years of quarterly data

All positions including Adaptive Biotechnologies Cor held by Susquehanna Portfolio Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptive Biotechnologies Cor by Susquehanna Portfolio Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.4M 229k 14.96
2025-06-30 $2.5M 219k 11.65

More positions owned by Susquehanna Portfolio Strategies

Oracle Corporation (ORCL)
Apple (AAPL)
Blackrock (BLK)
Merck & Co (MRK)
Arista Networks Com Shs (ANET)
Pfizer (PFE)
Amazon (AMZN)
Simon Property (SPG)
Baker Hughes Company Cl A (BKR)
Realty Income (O)
American Express Company (AXP)
Chipotle Mexican Grill (CMG)
Vulcan Materials Company (VMC)
General Motors Company (GM)
MetLife (MET)

View all positions for Susquehanna Portfolio Strategies

Top funds holding Adaptive Biotechnologies Cor

Viking Global Investors
BlackRock
Vanguard Group
Ameriprise Financial
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Geode Capital Management
ARK Investment Management
Aristotle Atlantic Partners
State Street Corporation
Driehaus Capital Management
Fred Alger Management
Arrowstreet Capital, Limited Partnership
Blue Water Life Science Advisors
Macquarie Group

View all funds holding Adaptive Biotechnologies Cor